Skip to main content
. 2022 Mar 3;14(3):560. doi: 10.3390/pharmaceutics14030560

Table 3.

Release rate for DOX: in vitro release data fitted with different models.

Nanogel Conditions for Release a First Order
(k; r2) b
Higuchi
(k; r2) c
Peppas
(k; n; r2) d
NG3 Healthy 0.026; 0.86 0.078; 0.99 0.114; 0.17; 0.98
Cancer 0.043; 0.99 0.166; 0.91 0.208; 0.36; 0.98
NG4 Healthy 0.019; 0.96 0.056; 0.88 0.081; 0.37; 0.93
Cancer 0.107; 0.92 0.208; 0.98 0.389; 0.17; 0.94
NG5 Healthy 0.087; 0.91 0.054; 0.87 0.185; 0.10; 0.99
Cancer 0.176; 0.92 0.215; 0.88 0.196; 0.41; 0.90
NG6 Healthy 0.032; 0.99 0.069; 0.86 0.122; 0.39; 0.99
Cancer 0.065; 0.98 0.126; 0.83 0.218; 0.30; 0.99

a Mimic healthy (pH 7.4 and 37 °C) and cancer (pH 6 and 40 °C) tissue conditions. b Obtained by Equation (4). c Obtained by Equation (5). d Obtained by Equation (6).